subject: Johnson Recalled Doors: Management Of Loss Of Brand Reputation In Exchange For Another Overdraft - [print this page] . April 30, its affiliated companies McNeil issued a statement the night of April 30, to product quality can not meet the standard completely ground, emergency recall of 40 kinds of non-prescription drugs, making Johnson & Johnson once again into a new round of product quality and whirlpool, the "Recall the door" in the storm again and again within a few days, let us comb the development of the incident.
The first day (April 30) Origin of a company by the Johnson & Johnson subsidiary McNeil night statement, a statement that Johnson would be in the United States, Canada and 12 countries and regions, with a recall of infant cold antipyretics Tainuo Lin, Merrill Lynch, anti- allergy drug Zyrtec and sensitive and so can his more than 40 kinds of non-prescription drugs. The reason is the quality of these products can not meet the standard completely.
Same time, the company said it also is in consultation with the U.S. Food and Drug Administration, the company voluntarily recalled more than drugs.
The next day (May 1) U.S. Food and Drug Administration (FDA) issued a circular to remind consumers to use caution with ibuprofen ingredients Tainuo Lin, Merrill Lynch and other drugs, although manufacturers to promote their cause minimal risk of serious adverse reactions. This is the second drug manufacturers announced the recall of drug-related notice after another.
Third day (May 2) FDA is to investigate Johnson recalls
U.S. Food and Drug Administration spokesman Elaine? Bobo said that the Authority is currently investigating the Johnson & Johnson Pharmaceutical recall.
The fifth day (May 4) U.S. Food and Drug Administration said in a report, the agency investigators in the U.S. pharmaceutical giant Johnson & Johnson in Fort Washington, Pennsylvania, pharmaceutical companies found a large amount of dust and contaminated ingredients, some pharmaceutical raw materials contamination. Johnson & Johnson by the end of April announced the recall of 40 kinds of drugs is the infants produced by the plant.
Johnson & Johnson said on that day, the quality of the plant "unacceptable", the company will work closely with the U.S. FDA to address this issue. The pharmaceutical companies are now discontinued.
On the "recall the door", the U.S. wine critics think that if Johnson did not recall a good deal, the next may cause a range of issues. "Johnson seems to conceal something, or do not fully open some of the information, and if so, then they will be injured."
, A subsidiary of contamination in raw materials after the deposit is still producing a steady stream of quality products, quality supervision departments until after the investigation found, it shows that Johnson & Johnson in the management of serious omission. This is widely known in the world, pharmaceutical companies have indeed should not, this incident will undoubtedly produce another blow to the reputation of Johnson & Johnson.
The saying goes, "Water boat, the vessel" is the enterprise survival consumers the parents of a good corporate reputation can gather more consumers to get more consumers. On the contrary, again and again the challenge of consumer trust in brands and products, it can only be playing with fire. Especially for drug quality problems have frequently been "entangled" in the pharmaceutical giants, is not that more thought and practical action.
